Señales en vivo de IXC.AX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 21:16):

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial...

Stats
Volumen de hoy	17 121.00
Volumen promedio	39 298.00
Capitalización de mercado	6.31M
EPS	$0 ( 2024-02-16 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.050
ATR14	$0 (0.00%)

Invex Therapeutics Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Invex Therapeutics Ltd Finanzas

Annual	2023
Ingresos:	$459 085
Beneficio Bruto:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2023
Ingresos:	$459 085
Beneficio Bruto:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2022
Ingresos:	$182 251
Beneficio Bruto:	$182 251 (100.00 %)
EPS:	$-0.0526

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.0407

Financial Reports:

No articles found.

Invex Therapeutics Ltd